{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:15:48Z","timestamp":1792782948742,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Monash University","id":[{"id":"https:\/\/ror.org\/02bfwt286","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging. Inform. med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Molecular markers are central to diagnosis, prognosis, and treatment selection in adult-type diffuse high-grade gliomas (HGG), but tissue genotyping is invasive and may be affected by intratumoral heterogeneity. We evaluated the diagnostic accuracy of AI-based MRI radiogenomics for preoperative molecular characterization of HGG. Following PRISMA 2020, we searched PubMed, EMBASE, Scopus, and bioRxiv on March 14, 2026, for studies using AI on preoperative MRI to predict molecular markers in HGG. Risk of bias was assessed using QUADAS-2; reporting and methodological quality were assessed with CLEAR and RQS. Diagnostic accuracy was pooled using bivariate random-effects models, with heterogeneity, prediction intervals, Deeks\u2019 test, and meta-regression evaluated. Nineteen studies were included (18 contributing 22 model estimates). Diagnostic performance was highest for ATRX loss (pooled sensitivity 0.932, specificity 0.915, and DOR 146.33) and IDH mutation (sensitivity 0.851, specificity 0.836, and DOR 35.43). MGMT promoter methylation demonstrated moderate performance (sensitivity 0.758, specificity 0.750, and DOR 10.20) with high heterogeneity (\n                    <jats:italic>I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u200982%). EGFR and PTEN showed limited utility (DORs 4.54 and 6.36). Performance fell markedly when restricted to externally validated cohorts (MGMT DOR 4.35 vs. 10.20 overall). Risk of bias was high in the index test domain for 79% of studies, with no significant publication bias (Deeks\u2019\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.109). AI-based MRI radiogenomics is a promising preoperative adjunct, particularly for IDH typing, but standardized, transparent, externally validated studies are needed. Pooled estimates dominated by internal validation likely overestimate real-world performance.\n                  <\/jats:p>","DOI":"10.1007\/s10278-026-02290-7","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:54Z","timestamp":1790356074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial Intelligence for the Preoperative Molecular Characterization of Adult-Type Diffuse High-Grade Gliomas: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8771-2163","authenticated-orcid":false,"given":"Jeremiah Hilkiah","family":"Wijaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiley Braxton V.","family":"Gillam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris B.","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Ruchika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouria","family":"Abolfazli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela A.","family":"Perez-Chadid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aafreen","family":"Azmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo Avila","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis O.","family":"Tierradentro-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Lucke-Wold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"2290_CR1","doi-asserted-by":"publisher","first-page":"1679634","DOI":"10.3389\/fonc.2025.1679634","volume":"15","author":"M Astaraki","year":"2025","unstructured":"Astaraki M, Lazzeroni M, Toma-Dasu I (2025) A comprehensive evaluation of MRI-based radiogenomics and prognosis prediction in glioma. Front Oncol 15:1679634. https:\/\/doi.org\/10.3389\/fonc.2025.1679634","journal-title":"Front Oncol"},{"issue":"1","key":"2290_CR2","doi-asserted-by":"publisher","first-page":"11852","DOI":"10.1038\/s41598-020-68857-8","volume":"10","author":"E Calabrese","year":"2020","unstructured":"Calabrese E, Villanueva-Meyer JE, Cha S (2020) A fully automated artificial intelligence method for non-invasive, imaging-based identification of genetic alterations in glioblastomas. Sci Rep 10(1):11852. https:\/\/doi.org\/10.1038\/s41598-020-68857-8","journal-title":"Sci Rep"},{"key":"2290_CR3","doi-asserted-by":"publisher","unstructured":"Chai R, Li G, Liu Y, Zhang K, Zhao Z, Wu F, Chang Y, Pang B, Li J, Li Y, Jiang T, Wang Y (2021) Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma. Cancer Biol Med 18(1):271\u2013282. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0179","DOI":"10.20892\/j.issn.2095-3941.2020.0179"},{"issue":"1","key":"2290_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41746-022-00699-2","volume":"5","author":"H Chen","year":"2022","unstructured":"Chen H, Gomez C, Huang C-M, Unberath M (2022) Explainable medical imaging AI needs human-centered design: guidelines and evidence from a systematic review. NPJ Digit Med 5(1):156. https:\/\/doi.org\/10.1038\/s41746-022-00699-2","journal-title":"NPJ Digit Med"},{"key":"2290_CR5","doi-asserted-by":"publisher","first-page":"9258649","DOI":"10.1155\/2020\/9258649","volume":"2020","author":"X Chen","year":"2020","unstructured":"Chen X, Zeng M, Tong Y, Zhang T, Fu Y, Li H, Zhang Z, Cheng Z, Xu X, Yang R, Liu Z, Wei X, Jiang X (2020) Automatic Prediction of MGMT Status in Glioblastoma via Deep Learning-Based MR Image Analysis. Biomed Res Int 2020:9258649. https:\/\/doi.org\/10.1155\/2020\/9258649","journal-title":"Biomed Res Int"},{"issue":"4","key":"2290_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/jon.12724","volume":"30","author":"G Crisi","year":"2020","unstructured":"Crisi G, Filice S (2020) Predicting MGMT Promoter Methylation of Glioblastoma from Dynamic Susceptibility Contrast Perfusion: A Radiomic Approach. J Neuroimaging 30(4):458\u2013462. https:\/\/doi.org\/10.1111\/jon.12724","journal-title":"J Neuroimaging"},{"issue":"1","key":"2290_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12967-023-04308-y","volume":"21","author":"M Dal Bo","year":"2023","unstructured":"Dal Bo M, Polano M, Ius T, Di Cintio F, Mondello A, Manini I, Pegolo E, Cesselli D, Di Loreto C, Skrap M, Toffoli G (2023) Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection. J Transl Med 21(1):450. https:\/\/doi.org\/10.1186\/s12967-023-04308-y","journal-title":"J Transl Med"},{"issue":"1","key":"2290_CR8","doi-asserted-by":"publisher","first-page":"13412","DOI":"10.1038\/s41598-022-17707-w","volume":"12","author":"DT Do","year":"2022","unstructured":"Do DT, Yang M-R, Lam LHT, Le NQK, Wu Y-W (2022) Improving MGMT methylation status prediction of glioblastoma through optimizing radiomics features using genetic algorithm-based machine learning approach. Sci Rep 12(1):13412. https:\/\/doi.org\/10.1038\/s41598-022-17707-w","journal-title":"Sci Rep"},{"issue":"1","key":"2290_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/ijms25010138","volume":"25","author":"FM Doniselli","year":"2023","unstructured":"Doniselli FM, Pascuzzo R, Agr\u00f2 M, Aquino D, Anghileri E, Farinotti M, Pollo B, Paterra R, Cuccarini V, Moscatelli M, DiMeco F, Sconfienza LM (2023) Development of A Radiomic Model for MGMT Promoter Methylation Detection in Glioblastoma Using Conventional MRI. Int J Mol Sci 25(1):138. https:\/\/doi.org\/10.3390\/ijms25010138","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2290_CR10","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.neuroimage.2009.09.049","volume":"49","author":"S Drabycz","year":"2010","unstructured":"Drabycz S, Rold\u00e1n G, de Robles P, Adler D, McIntyre JB, Magliocco AM, Cairncross JG, Mitchell JR (2010) An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Neuroimage 49(2):1398\u20131405. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.09.049","journal-title":"Neuroimage"},{"issue":"9","key":"2290_CR11","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/biomedicines13092285","volume":"13","author":"K Evangelou","year":"2025","unstructured":"Evangelou K, Kotsantis I, Kalyvas A, Kyriazoglou A, Economopoulou P, Velonakis G, Gavra M, Psyrri A, Boviatsis EJ, Stavrinou LC (2025) Artificial Intelligence in the Diagnosis and Treatment of Brain Gliomas. Biomedicines 13(9):2285. https:\/\/doi.org\/10.3390\/biomedicines13092285","journal-title":"Biomedicines"},{"issue":"1","key":"2290_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40644-024-00682-y","volume":"24","author":"H Fan","year":"2024","unstructured":"Fan H, Luo Y, Gu F, Tian B, Xiong Y, Wu G, Nie X, Yu J, Tong J, Liao X (2024) Artificial intelligence-based MRI radiomics and radiogenomics in glioma. Cancer Imaging 24(1):36. https:\/\/doi.org\/10.1186\/s40644-024-00682-y","journal-title":"Cancer Imaging"},{"issue":"2","key":"2290_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","volume":"49","author":"E Guedj","year":"2022","unstructured":"Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Pe\u00f1uelas I, Semah F, Traub-Weidinger T, van de Giessen E, Van Weehaeghe D, Morbelli S (2022) EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3. Eur J Nucl Med Mol Imaging 49(2):632\u2013651. https:\/\/doi.org\/10.1007\/s00259-021-05603-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"2290_CR14","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.230437","volume":"6","author":"N Horvat","year":"2024","unstructured":"Horvat N, Papanikolaou N, Koh D-M (2024) Radiomics Beyond the Hype: A Critical Evaluation Toward Oncologic Clinical Use. Radiol Artif Intell 6(4):e230437. https:\/\/doi.org\/10.1148\/ryai.230437","journal-title":"Radiol Artif Intell"},{"issue":"1","key":"2290_CR15","doi-asserted-by":"publisher","DOI":"10.1117\/1.JMI.11.1.014503","volume":"11","author":"M Hu","year":"2024","unstructured":"Hu M, Yang K, Wang J, Qiu RLJ, Roper J, Kahn S, Shu H-K, Yang X (2024) MGMT promoter methylation prediction based on multiparametric MRI via vision graph neural network. J Med Imaging (Bellingham) 11(1):014503. https:\/\/doi.org\/10.1117\/1.JMI.11.1.014503","journal-title":"J Med Imaging (Bellingham)"},{"key":"2290_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cmpb.2016.12.018","volume":"140","author":"VG Kanas","year":"2017","unstructured":"Kanas VG, Zacharaki EI, Thomas GA, Zinn PO, Megalooikonomou V, Colen RR (2017) Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma. Comput Methods Programs Biomed 140:249\u2013257. https:\/\/doi.org\/10.1016\/j.cmpb.2016.12.018","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"2290_CR17","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1148\/radiol.2016161382","volume":"281","author":"P Kickingereder","year":"2016","unstructured":"Kickingereder P, Bonekamp D, Nowosielski M, Kratz A, Sill M, Burth S, Wick A, Eidel O, Schlemmer H-P, Radbruch A, Debus J, Herold-Mende C, Unterberg A, Jones D, Pfister S, Wick W, von Deimling A, Bendszus M, Capper D (2016) Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features. Radiology 281(3):907\u2013918. https:\/\/doi.org\/10.1148\/radiol.2016161382","journal-title":"Radiology"},{"issue":"1","key":"2290_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13244-023-01415-8","volume":"14","author":"B Kocak","year":"2023","unstructured":"Kocak B, Baessler B, Bakas S, Cuocolo R, Fedorov A, Maier-Hein L, Mercaldo N, M\u00fcller H, Orlhac F, Pinto Dos Santos D, Stanzione A, Ugga L, Zwanenburg A (2023) CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII. Insights Imaging 14(1):75. https:\/\/doi.org\/10.1186\/s13244-023-01415-8","journal-title":"Insights Imaging"},{"key":"2290_CR19","doi-asserted-by":"publisher","unstructured":"Ko\u00e7ak B, D\u2019Antonoli TA, Cuocolo R (2024) Exploring radiomics research quality scoring tools: a comparative analysis of METRICS and RQS. Diagn Interv Radiol. 2024 Nov 6;30(6):366\u2013369. https:\/\/doi.org\/10.4274\/dir.2024.242793","DOI":"10.4274\/dir.2024.242793"},{"issue":"6","key":"2290_CR20","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1118\/1.4948668","volume":"43","author":"P Korfiatis","year":"2016","unstructured":"Korfiatis P, Kline TL, Coufalova L, Lachance DH, Parney IF, Carter RE, Buckner JC, Erickson BJ (2016) MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas. Med Phys 43(6):2835\u20132844. https:\/\/doi.org\/10.1118\/1.4948668","journal-title":"Med Phys"},{"issue":"1","key":"2290_CR21","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1038\/s41598-025-87803-0","volume":"15","author":"\u0130\u00d6 Koska","year":"2025","unstructured":"Koska \u0130\u00d6, Koska \u00c7 (2025) Deep learning classification of MGMT status of glioblastomas using multiparametric MRI with a novel domain knowledge augmented mask fusion approach. Sci Rep 15(1):3273. https:\/\/doi.org\/10.1038\/s41598-025-87803-0","journal-title":"Sci Rep"},{"issue":"13","key":"2290_CR22","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.3390\/cancers15133416","volume":"15","author":"HW Lee","year":"2023","unstructured":"Lee HW, Kim E, Na I, Kim CK, Seo SI, Park H (2023) Novel Multiparametric Magnetic Resonance Imaging-Based Deep Learning and Clinical Parameter Integration for the Prediction of Long-Term Biochemical Recurrence-Free Survival in Prostate Cancer after Radical Prostatectomy. Cancers (Basel) 15(13):3416. https:\/\/doi.org\/10.3390\/cancers15133416","journal-title":"Cancers (Basel)"},{"key":"2290_CR23","doi-asserted-by":"publisher","unstructured":"Leske H, Camenisch Gross U, Hofer S, Neidert MC, Leske S, Weller M, Lehnick D, Rushing EJ (2023) MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value. acta neuropathol commun 11(1):139. https:\/\/doi.org\/10.1186\/s40478-023-01622-w","DOI":"10.1186\/s40478-023-01622-w"},{"issue":"1","key":"2290_CR24","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/s41598-024-66653-2","volume":"14","author":"L Li","year":"2024","unstructured":"Li L, Xiao F, Wang S, Kuang S, Li Z, Zhong Y, Xu D, Cai Y, Li S, Chen J, Liu Y, Li J, Li H, Xu H (2024) Preoperative prediction of MGMT promoter methylation in glioblastoma based on multiregional and multi-sequence MRI radiomics analysis. Sci Rep 14(1):16031. https:\/\/doi.org\/10.1038\/s41598-024-66653-2","journal-title":"Sci Rep"},{"issue":"11","key":"2290_CR25","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00234-019-02244-7","volume":"61","author":"Y Li","year":"2019","unstructured":"Li Y, Liang Y, Sun Z, Xu K, Fan X, Li S, Zhang Z, Jiang T, Liu X, Wang Y (2019) Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging. Neuroradiology 61(11):1229\u20131237. https:\/\/doi.org\/10.1007\/s00234-019-02244-7","journal-title":"Neuroradiology"},{"issue":"8","key":"2290_CR26","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"issue":"7956","key":"2290_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-023-05881-4","volume":"616","author":"M Moor","year":"2023","unstructured":"Moor M, Banerjee O, Shakeri Hossein Abad Z, Krumholz HM, Leskovec J, Topol EJ, Rajpurkar P (2023) Foundation models for generalist medical artificial intelligence. Nature 616(7956):259\u2013265. https:\/\/doi.org\/10.1038\/s41586-023-05881-4","journal-title":"Nature"},{"issue":"1","key":"2290_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10143-025-03419-y","volume":"48","author":"I Mohammadzadeh","year":"2025","unstructured":"Mohammadzadeh I, Hajikarimloo B, Niroomand B, Eini P, Ghanbarnia R, Habibi MA, Albakr A, Borghei-Razavi H (2025) Application of artificial intelligence in forecasting survival in high-grade glioma: systematic review and meta-analysis involving 79,638 participants. Neurosurg Rev 48(1):240. https:\/\/doi.org\/10.1007\/s10143-025-03419-y","journal-title":"Neurosurg Rev"},{"issue":"1","key":"2290_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"2290_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"3","key":"2290_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s42256-024-00807-9","volume":"6","author":"S Pai","year":"2024","unstructured":"Pai S, Bontempi D, Hadzic I, Prudente V, Soka\u010d M, Chaunzwa TL, Bernatz S, Hosny A, Mak RH, Birkbak NJ, Aerts HJWL (2024) Foundation model for cancer imaging biomarkers. Nat Mach Intell 6(3):354\u2013367. https:\/\/doi.org\/10.1038\/s42256-024-00807-9","journal-title":"Nat Mach Intell"},{"issue":"4","key":"2290_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3174\/ajnr.A5569","volume":"39","author":"YW Park","year":"2018","unstructured":"Park YW, Han K, Ahn SS, Choi YS, Chang JH, Kim SH, Kang S-G, Kim EH, Lee S-K (2018) Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of IDH1-Mutation and 1p\/19q-Codeletion Status in World Health Organization Grade II Gliomas. AJNR Am J Neuroradiol 39(4):693\u2013698. https:\/\/doi.org\/10.3174\/ajnr.A5569","journal-title":"AJNR Am J Neuroradiol"},{"key":"2290_CR33","doi-asserted-by":"crossref","unstructured":"Pasquini L, Napolitano A, Lucignani M, Tagliente E, Dellepiane F, Rossi-Espagnet MC, Ritrovato M, Vidiri A, Villani V, Ranazzi G, Stoppacciaro A, Romano A, Di Napoli A, Bozzao A (2021) Comparison of machine learning classifiers to predict patient survival and genetics of GBM: towards a standardized model for clinical implementation","DOI":"10.2196\/preprints.32594"},{"issue":"9","key":"2290_CR34","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.3390\/cancers15092573","volume":"15","author":"R Paudyal","year":"2023","unstructured":"Paudyal R, Shah AD, Akin O, Do RKG, Konar AS, Hatzoglou V, Mahmood U, Lee N, Wong RJ, Banerjee S, Shin J, Veeraraghavan H, Shukla-Dave A (2023) Artificial Intelligence in CT and MR Imaging for Oncological Applications. Cancers (Basel) 15(9):2573. https:\/\/doi.org\/10.3390\/cancers15092573","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2290_CR35","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AWS, Scholten RJPM, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58(10):982\u2013990. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.02.022","journal-title":"J Clin Epidemiol"},{"issue":"13","key":"2290_CR36","doi-asserted-by":"publisher","first-page":"11110","DOI":"10.3390\/ijms241311110","volume":"24","author":"SMB Rodriguez","year":"2023","unstructured":"Rodriguez SMB, Kamel A, Ciubotaru GV, Onose G, Sevastre A-S, Sfredel V, Danoiu S, Dricu A, Tataranu LG (2023) An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma. Int J Mol Sci 24(13):11110. https:\/\/doi.org\/10.3390\/ijms241311110","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2290_CR37","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/neuonc\/noab239","volume":"24","author":"R Rud\u00e0","year":"2022","unstructured":"Rud\u00e0 R, Bruno F, Ius T, Silvani A, Minniti G, Pace A, Lombardi G, Bertero L, Pizzolitto S, Pollo B, Conti Nibali M, Pellerino A, Migliore E, Skrap M, Bello L, Soffietti R (2022) IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups. Neuro Oncol 24(5):809\u2013820. https:\/\/doi.org\/10.1093\/neuonc\/noab239","journal-title":"Neuro Oncol"},{"issue":"1","key":"2290_CR38","doi-asserted-by":"publisher","first-page":"14435","DOI":"10.1038\/s41598-019-50849-y","volume":"9","author":"T Sasaki","year":"2019","unstructured":"Sasaki T, Kinoshita M, Fujita K, Fukai J, Hayashi N, Uematsu Y, Okita Y, Nonaka M, Moriuchi S, Uda T, Tsuyuguchi N, Arita H, Mori K, Ishibashi K, Takano K, Nishida N, Shofuda T, Yoshioka E, Kanematsu D, Kodama Y, Mano M, Nakao N, Kanemura Y (2019) Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma. Sci Rep 9(1):14435. https:\/\/doi.org\/10.1038\/s41598-019-50849-y","journal-title":"Sci Rep"},{"issue":"2","key":"2290_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-023-04435-y","volume":"164","author":"B Sohn","year":"2023","unstructured":"Sohn B, Park K, Ahn SS, Park YW, Choi SH, Kang S-G, Kim SH, Chang JH, Lee S-K (2023) Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype. J Neurooncol 164(2):341\u2013351. https:\/\/doi.org\/10.1007\/s11060-023-04435-y","journal-title":"IDH-wildtype. J Neurooncol"},{"issue":"6","key":"2290_CR40","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1109\/TMI.2020.2964310","volume":"39","author":"Z Tang","year":"2020","unstructured":"Tang Z, Xu Y, Jin L, Aibaidula A, Lu J, Jiao Z, Wu J, Zhang H, Shen D (2020) Deep Learning of Imaging Phenotype and Genotype for Predicting Overall Survival Time of Glioblastoma Patients. IEEE Trans Med Imaging 39(6):2100\u20132109. https:\/\/doi.org\/10.1109\/TMI.2020.2964310","journal-title":"IEEE Trans Med Imaging"},{"issue":"10","key":"2290_CR41","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/diagnostics15101292","volume":"15","author":"E Tasci","year":"2025","unstructured":"Tasci E, Zhuge Y, Zhang L, Ning H, Cheng JY, Miller RW, Camphausen K, Krauze AV (2025) Radiomics and AI-Based Prediction of MGMT Methylation Status in Glioblastoma Using Multiparametric MRI: A Hybrid Feature Weighting Approach. Diagnostics 15(10):1292. https:\/\/doi.org\/10.3390\/diagnostics15101292","journal-title":"Diagnostics"},{"key":"2290_CR42","doi-asserted-by":"publisher","unstructured":"Tejani AS, Klontzas ME, Gatti AA, Mongan JT, Moy L, Park SH, Kahn CE Jr, CLAIM 2024 Update Panel (2024) Checklist for Artificial Intelligence in Medical Imaging (CLAIM): 2024 Update. Radiol Artif Intell 6(4):e240300. https:\/\/doi.org\/10.1148\/ryai.240300","DOI":"10.1148\/ryai.240300"},{"issue":"5","key":"2290_CR43","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/jmri.25860","volume":"47","author":"Y-B Xi","year":"2018","unstructured":"Xi Y-B, Guo F, Xu Z-L, Li C, Wei W, Tian P, Liu T-T, Liu L, Chen G, Ye J, Cheng G, Cui L-B, Zhang H-J, Qin W, Yin H (2018) Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma. J Magn Reson Imaging 47(5):1380\u20131387. https:\/\/doi.org\/10.1002\/jmri.25860","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"2290_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3174\/ajnr.A7029","volume":"42","author":"CGB Yogananda","year":"2021","unstructured":"Yogananda CGB, Shah BR, Nalawade SS, Murugesan GK, Yu FF, Pinho MC, Wagner BC, Mickey B, Patel TR, Fei B, Madhuranthakam AJ, Maldjian JA (2021) MRI-Based Deep-Learning Method for Determining Glioma MGMT Promoter Methylation Status. AJNR Am J Neuroradiol 42(5):845\u2013852. https:\/\/doi.org\/10.3174\/ajnr.A7029","journal-title":"AJNR Am J Neuroradiol"},{"key":"2290_CR45","doi-asserted-by":"publisher","unstructured":"Yu AC, Mohajer B, Eng J (2022) External Validation of Deep Learning Algorithms for Radiologic Diagnosis: A Systematic Review. Radiology: Artificial Intelligence 4(3):e210064. https:\/\/doi.org\/10.1148\/ryai.210064","DOI":"10.1148\/ryai.210064"},{"issue":"1","key":"2290_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40779-023-00458-8","volume":"10","author":"Y-P Zhang","year":"2023","unstructured":"Zhang Y-P, Zhang X-Y, Cheng Y-T, Li B, Teng X-Z, Zhang J, Lam S, Zhou T, Ma Z-R, Sheng J-B, Tam VCW, Lee SWY, Ge H, Cai J (2023) Artificial intelligence-driven radiomics study in cancer: the role of feature engineering and modeling. Military Med Res 10(1):22. https:\/\/doi.org\/10.1186\/s40779-023-00458-8","journal-title":"Military Med Res"}],"container-title":["Journal of Imaging Informatics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-026-02290-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-026-02290-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-026-02290-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:56Z","timestamp":1790356076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-026-02290-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":46,"alternative-id":["2290"],"URL":"https:\/\/doi.org\/10.1007\/s10278-026-02290-7","relation":{},"ISSN":["2948-2933"],"issn-type":[{"value":"2948-2933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"17 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was a systematic review and meta-analysis of previously published literature. It did not involve the recruitment of human participants, the collection of new patient data, or access to identifiable private information. Therefore, approval from an institutional review board or research ethics committee was not required.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study used data obtained exclusively from previously published studies and did not directly involve human participants.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The manuscript does not contain identifiable personal information, individual patient data, images, or other materials requiring consent for publication.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}